HUT52500A - Process for producing antibacterial 1-terc-alkyl-substituted naphtiridine- and quinoline-carboxylic acids and pharmaceutical compositions containing them as active components - Google Patents
Process for producing antibacterial 1-terc-alkyl-substituted naphtiridine- and quinoline-carboxylic acids and pharmaceutical compositions containing them as active componentsInfo
- Publication number
- HUT52500A HUT52500A HU875686A HU568787A HUT52500A HU T52500 A HUT52500 A HU T52500A HU 875686 A HU875686 A HU 875686A HU 568787 A HU568787 A HU 568787A HU T52500 A HUT52500 A HU T52500A
- Authority
- HU
- Hungary
- Prior art keywords
- naphtiridine
- terc
- quinoline
- substituted
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91675286A | 1986-10-08 | 1986-10-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUT52500A true HUT52500A (en) | 1990-07-28 |
Family
ID=25437769
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU875686A HUT52500A (en) | 1986-10-08 | 1987-10-08 | Process for producing antibacterial 1-terc-alkyl-substituted naphtiridine- and quinoline-carboxylic acids and pharmaceutical compositions containing them as active components |
HU875686A HU203753B (en) | 1986-10-08 | 1987-10-08 | Process for producing 1-terc-alkyl-substituted naphtiridine and quinoline-carboxylic acids and pharmaceutical compositions contianing them |
HU911136A HU911136D0 (en) | 1986-10-08 | 1987-10-08 | Process for producing 1-tertiary-alkyl-substituted naphtyridine- and quinoline-carbonic acid derivatives and intermediate products |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU875686A HU203753B (en) | 1986-10-08 | 1987-10-08 | Process for producing 1-terc-alkyl-substituted naphtiridine and quinoline-carboxylic acids and pharmaceutical compositions contianing them |
HU911136A HU911136D0 (en) | 1986-10-08 | 1987-10-08 | Process for producing 1-tertiary-alkyl-substituted naphtyridine- and quinoline-carbonic acid derivatives and intermediate products |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0288519A4 (en) |
AU (2) | AU611400B2 (en) |
DD (2) | DD266354A5 (en) |
EG (1) | EG18484A (en) |
FI (1) | FI883894A0 (en) |
HU (3) | HUT52500A (en) |
WO (1) | WO1988002627A1 (en) |
ZA (1) | ZA877471B (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62108878A (en) * | 1985-11-05 | 1987-05-20 | Kyorin Pharmaceut Co Ltd | Quinolonecarboxylic acid derivative and production thereof |
CA1336090C (en) * | 1988-08-31 | 1995-06-27 | Isao Hayakawa | Spiro-substituted cyclic amines of quinolone derivatives |
US5286723A (en) * | 1988-08-31 | 1994-02-15 | Daiichi Seiyaku Co., Ltd. | Spiro compound |
CA1332605C (en) * | 1988-10-03 | 1994-10-18 | Yasuhiro Nishitani | Pyridonecarboxylic acids |
US5262417A (en) * | 1988-12-06 | 1993-11-16 | The Upjohn Company | Antibacterial quinolone compounds |
US4916141A (en) * | 1989-03-28 | 1990-04-10 | Warner-Lambert Company | (S)-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid |
AU618460B2 (en) * | 1989-04-18 | 1991-12-19 | Hokuriku Pharmaceutical Co. Ltd. | Thiazetoquinoline-3-carboxylic acid derivative, method for preparation thereof, and a pharmaceutical composition comprising the same |
US5342846A (en) * | 1990-12-05 | 1994-08-30 | Synphar Laboratories, Inc. | 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents |
TW425394B (en) * | 1996-04-24 | 2001-03-11 | Daiichi Seiyaku Co | Antimicrobial quinolone derivatives having 3-(N-cycloalkyl) aminomethylpyrrolidine group |
US6872742B2 (en) | 1996-08-28 | 2005-03-29 | The Procter & Gamble Company | Substituted cyclic amine metalloprotease inhibitors |
PL331802A1 (en) | 1996-08-28 | 1999-08-02 | Procter & Gamble | Substituted cyclic amines as metaloprotease inhibitors |
BR9810841A (en) | 1997-07-31 | 2001-07-10 | Procter & Gamble | Alicyclic metalloprotease inhibitors |
US6197770B1 (en) | 1999-03-03 | 2001-03-06 | The Procter & Gamble Co. | Alkenyl- and alkynl-containing metalloprotease inhibitors |
SE0003795D0 (en) | 2000-10-20 | 2000-10-20 | Astrazeneca Ab | Pharmaceutically useful compounds |
BR0314201A (en) | 2002-09-10 | 2005-07-12 | Pfizer Prod Inc | Diazabicyclic Compounds Useful in the Treatment of CNS Diseases and Other Disorders |
US7648980B2 (en) * | 2005-01-25 | 2010-01-19 | Glaxo Group Limited | Antibacterial agents |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH408036A (en) * | 1960-02-17 | 1966-02-28 | Lepetit Spa | Process for the preparation of 3,8-diazabicyclo- (3,2,1) -octane-2,4-dione |
GB937183A (en) * | 1960-02-17 | 1963-09-18 | Lepetit Spa | 3,8-diazabicyclo-[3,2,1]-octanes |
DE2808070A1 (en) * | 1978-02-24 | 1979-08-30 | Bayer Ag | PROCESS FOR THE PRODUCTION OF 4-PYRIDONE-3-CARBONIC ACIDS AND / OR DERIVATIVES |
GB2093018B (en) * | 1979-08-22 | 1984-09-12 | Kyorin Seiyaku Kk | 6,8-difluoro-quinoline carboxylic acid derivatives |
JPS5649382A (en) * | 1979-09-28 | 1981-05-02 | Dainippon Pharmaceut Co Ltd | 6-fluoro-7-cyclic amino-1,8-naphthylidine derivative and its salt |
US4665079A (en) * | 1984-02-17 | 1987-05-12 | Warner-Lambert Company | Antibacterial agents |
US4571396A (en) * | 1984-04-16 | 1986-02-18 | Warner-Lambert Company | Antibacterial agents |
DE3509546A1 (en) * | 1985-03-16 | 1986-09-25 | Bayer Ag, 5090 Leverkusen | 7-AMINO-1- (SUBST.CYCLOPROPYL) -1,4-DIHYDRO-4-OXO-3-CHINOLINE CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE ANTIBACTERIAL AGENTS CONTAINING THEM |
US4578473A (en) * | 1985-04-15 | 1986-03-25 | Warner-Lambert Company | Process for quinoline-3-carboxylic acid antibacterial agents |
US4772706A (en) * | 1986-01-13 | 1988-09-20 | Warner-Lambert Company | Process for quinoline-3-carboxylic acid antibacterial agents |
DE3601567A1 (en) * | 1986-01-21 | 1987-07-23 | Bayer Ag | 7- (AZABICYCLOALKYL) -CHINOLONCARBONIC ACID AND -NAPHTHYRIDON-CARBONIC ACID DERIVATIVES |
-
1987
- 1987-10-05 ZA ZA877471A patent/ZA877471B/en unknown
- 1987-10-06 DD DD87307706A patent/DD266354A5/en not_active IP Right Cessation
- 1987-10-06 DD DD87327989A patent/DD280530A5/en not_active IP Right Cessation
- 1987-10-07 EG EG579/87A patent/EG18484A/en active
- 1987-10-08 WO PCT/US1987/002556 patent/WO1988002627A1/en not_active Application Discontinuation
- 1987-10-08 HU HU875686A patent/HUT52500A/en unknown
- 1987-10-08 HU HU875686A patent/HU203753B/en not_active IP Right Cessation
- 1987-10-08 AU AU81581/87A patent/AU611400B2/en not_active Ceased
- 1987-10-08 HU HU911136A patent/HU911136D0/en not_active IP Right Cessation
- 1987-10-08 EP EP19870907178 patent/EP0288519A4/en active Pending
-
1988
- 1988-08-23 FI FI883894A patent/FI883894A0/en not_active Application Discontinuation
-
1991
- 1991-05-01 AU AU76326/91A patent/AU7632691A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HU203753B (en) | 1991-09-30 |
FI883894A (en) | 1988-08-23 |
DD266354A5 (en) | 1989-03-29 |
WO1988002627A1 (en) | 1988-04-21 |
EG18484A (en) | 1993-04-30 |
AU611400B2 (en) | 1991-06-13 |
DD280530A5 (en) | 1990-07-11 |
EP0288519A4 (en) | 1992-04-15 |
EP0288519A1 (en) | 1988-11-02 |
ZA877471B (en) | 1988-04-05 |
HU911136D0 (en) | 1991-10-28 |
FI883894A0 (en) | 1988-08-23 |
AU7632691A (en) | 1991-08-08 |
AU8158187A (en) | 1988-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT54999A (en) | Process for producing imidazolyl-alkenic acids and pharmaceutical compositions containing them as active components | |
HUT46710A (en) | Process for producing peptode derivatives and pharmaceutical compositions containing them as active components | |
HUT47274A (en) | Process for producing terciary hydroxy-alkyl-xantines and pharmaceutical compositions containing them as active components | |
HUT46699A (en) | Process for producing phosphinic acid derivatives and pharmaceutical compositions containing them as active components | |
HU199453B (en) | Process for producing quinoloncarboxylic acid derivatives and pharmaceutical compositions comprising same | |
HUT45252A (en) | Process for producing imidazo-pyridine derivatives and pharmaceutical compositions containing them as active components | |
HUT46654A (en) | Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient | |
HUT47131A (en) | Process for producing steroid-5alpha-reductase inhibitors and pharmaceutical compositions comprising them as active ingredient | |
HUT48247A (en) | Process for producing aza-bicyclo-octyl-ether derivatives and pharmaceutical compositions containing them as active components | |
HUT51279A (en) | Process for producing 2-phosphate-esters of ascorbinic acid and pharmaceutical compositions containing them as active components | |
HUT48609A (en) | Process for producing kumaran derivatives and pharmaceutical compositions comprising same as active ingredient | |
PT85886A (en) | Process for producing 1-tertiary-alkyl-substituted naphthrydine-carboxylic and quinoline-carboxylic acids and pharmaceutic compositions containing them and starting compounds | |
HUT48246A (en) | Process for producing n-substituted benzamides and pharmaceutical compositions containing them as active components | |
HU200177B (en) | Process for producing thiazolidinecarboxylic acids and pharmaceutical compositions comprising such compounds | |
HUT52500A (en) | Process for producing antibacterial 1-terc-alkyl-substituted naphtiridine- and quinoline-carboxylic acids and pharmaceutical compositions containing them as active components | |
HUT47865A (en) | Process for producing pharmaceutical compositions containing somatostatin as active component | |
HUT49494A (en) | Process for producing active component of pharmaceutical compositions | |
HUT46645A (en) | Process for producing alpha-halogen-dicarboxylic acids and their derivatives and pharmaceutical compositions comprising the same | |
HUT54671A (en) | Process for producing benzothiopirane derivatives and pharmaceutical compositions containing them as active component | |
HUT50473A (en) | Process for producing imidazopyridazinones and pharmaceutical compositions comprising such compounds | |
HUT45540A (en) | Process for producing beta-lactame compounds and pharmaceutical compositions containing them as active componenets | |
HUT48251A (en) | Process for producing new xantin derivatives and pharmaceutical compositions containing them as active components | |
HUT46930A (en) | Process for producing aminoglycoside-steroides and pharmaceutical compositions containing them as active components | |
HUT50112A (en) | Process for producing phenoxyalkyl-carboxylic acid derivatives and pharmaceutical compositions containing them as active component | |
HUT49598A (en) | Process for producing chromone derivatives and pharmaceutical compositions comprising same as active ingredient |